Search Results

. Hansa Biopharma, “Hansa”, announced data featuring imlifidase will be presented at the American Transplant Congress, the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.

Invivyd, Inc. announced that it will present preliminary, subset analyses from the CANOPY Phase 3 clinical trial of VYD222 for pre-exposure prophylaxis of COVID-19 at the 2024 American Society of Clinical Oncology Annual Meeting and at the 2024 American Transplant Congress.

NMDP℠, a global nonprofit leader in cell therapy, and CIBMTR® (Center for International Blood and Marrow Transplant Research®) will present new data on hematopoietic cell transplantation (HCT) treatment effects in patients with hematological malignancies at the American Society of Clinical Oncology (ASCO) Annual Meeting May 31–June 4, 2024, in Chicago, Ill., and online.

The American Society for Transplantation and Cellular Therapy® (ASTCT) will present Robin Roberts, Good Morning America anchor, with its 2024 Public Service Award at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® on Friday, February 23.

Veloxis Pharmaceuticals, Inc. is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).

CareDx, Inc. announced a leading presence and the fifth consecutive year as the Distinguished Founder’s Circle Sponsor for the Annual American Society of Transplant Surgeons Winter Symposium being held January 11 - 14, 2024 in Miami, Florida.